1 authorised product containing Autologous Peripheral Blood T Cells CD4 and CD8 selected and CD3 and CD28 Activated Transduced with Retroviral Vectir Expressing Anti CD19 CD28/CD3-Zeta Chimeric Antigen Receptor and Cultured, from the HPRA register.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| Tecartus 0.4 – 2 × 108 cells dispersion for infusion EU/1/20/1492/001 |
Autologous Peripheral Blood T Cells CD4 and CD8 selected and CD3 and CD28 Activated Transduced with Retroviral Vectir Expressing Anti CD19 CD28/CD3-Zeta Chimeric Antigen Receptor and Cultured | Kite Pharma EU B.V. | — |
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 6 July 2026).
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.